Descriptor English: | Docetaxel | ||||||
Descriptor Spanish: |
Docetaxel
| ||||||
Descriptor Portuguese: | Docetaxel | ||||||
Descriptor French: | Docetaxel | ||||||
Entry term(s): |
Docetaxel Anhydrous Docetaxel Hydrate Docetaxel Trihydrate Docetaxol N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol NSC 628503 RP 56976 RP-56976 RP56976 Taxoltere Metro Taxotere |
||||||
Tree number(s): |
D02.455.426.392.368.242.888.389 D02.455.849.291.850.389 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077143 | ||||||
Scope note: | A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents Tubulin Modulators |
||||||
Registry Number: | 15H5577CQD | ||||||
CAS Type 1 Name: | Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aR,6R,9S,11S,12S,12aS,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,4a ,6,11-tetrahydroxy-8,12a,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR)-, hydrate (1:3) | ||||||
Public MeSH Note: | 2019; DOCETAXEL was indexed under TAXOIDS 1993-2018, and under ALKALOIDS 1991-1992 |
||||||
History Note: | 2019 (1991) |
||||||
DeCS ID: | 57515 | ||||||
Unique ID: | D000077143 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/07/02 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Docetaxel
- Preferred
Taxoltere Metro
- Narrower
RP 56976
- Narrower
Taxotere
- Narrower
Docetaxel Anhydrous
- Narrower
NSC 628503
- Narrower
Concept UI |
M0184558 |
Scope note | A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER. |
Preferred term | Docetaxel |
Entry term(s) |
Docetaxel Hydrate Docetaxel Trihydrate Docetaxol |
Concept UI |
M0357706 |
Preferred term | Taxoltere Metro |
Concept UI |
M0184554 |
Preferred term | RP 56976 |
Entry term(s) |
RP-56976 RP56976 |
Concept UI |
M0184556 |
Preferred term | Taxotere |
Concept UI |
M0585054 |
Preferred term | Docetaxel Anhydrous |
Entry term(s) |
N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol |
Concept UI |
M0184553 |
Preferred term | NSC 628503 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey